Literature DB >> 21423222

Maturation of effector regulatory T cells.

Naganari Ohkura1, Shimon Sakaguchi.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21423222     DOI： 10.1038/ni0411-283

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Authors:  Weiming Ouyang; Omar Beckett; Qian Ma; Ji-hye Paik; Ronald A DePinho; Ming O Li
Journal:  Nat Immunol       Date:  2010-05-13       Impact factor: 25.606

Review 2.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

3.  The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells.

Authors:  Erika Cretney; Annie Xin; Wei Shi; Martina Minnich; Frederick Masson; Maria Miasari; Gabrielle T Belz; Gordon K Smyth; Meinrad Busslinger; Stephen L Nutt; Axel Kallies
Journal:  Nat Immunol       Date:  2011-03-06       Impact factor: 25.606

4.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

5.  Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance.

Authors:  Axel Kallies; Edwin D Hawkins; Gabrielle T Belz; Donald Metcalf; Mirja Hommel; Lynn M Corcoran; Philip D Hodgkin; Stephen L Nutt
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

6.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function.

Authors:  Gislâine A Martins; Luisa Cimmino; Miriam Shapiro-Shelef; Matthias Szabolcs; Alan Herron; Erna Magnusdottir; Kathryn Calame
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

7.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

8.  Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells.

Authors:  Fan Pan; Hong Yu; Eric V Dang; Joseph Barbi; Xiaoyu Pan; Joseph F Grosso; Dinili Jinasena; Sudarshana M Sharma; Erin M McCadden; Derese Getnet; Charles G Drake; Jun O Liu; Michael C Ostrowski; Drew M Pardoll
Journal:  Science       Date:  2009-08-20       Impact factor: 47.728

Review 9.  BLIMP1 guides the fate of effector B and T cells.

Authors:  Stephen L Nutt; Kirsten A Fairfax; Axel Kallies
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

10.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962
View more
  10 in total

Review 1.  Highlights of the advances in basic immunology in 2011.

Authors:  Juan Liu; Shuxun Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

Review 2.  Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.

Authors:  Maryam Tahvildari; Afsaneh Amouzegar; William Foulsham; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2018-01-06       Impact factor: 9.261

3.  CD83 expression is essential for Treg cell differentiation and stability.

Authors:  Marina Doebbeler; Christina Koenig; Lena Krzyzak; Christine Seitz; Andreas Wild; Thomas Ulas; Kevin Baßler; Dmitry Kopelyanskiy; Alina Butterhof; Christine Kuhnt; Simon Kreiser; Lena Stich; Elisabeth Zinser; Ilka Knippertz; Stefan Wirtz; Christin Riegel; Petra Hoffmann; Matthias Edinger; Lars Nitschke; Thomas Winkler; Joachim L Schultze; Alexander Steinkasserer; Matthias Lechmann
Journal:  JCI Insight       Date:  2018-06-07

4.  PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome.

Authors:  Huidong Guo; Ming Wang; Bixia Wang; Liping Guo; Yifei Cheng; Zhidong Wang; Yu-Qian Sun; Yu Wang; Ying-Jun Chang; Xiao-Jun Huang
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

5.  The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.

Authors:  Akio Ohta; Radhika Kini; Akiko Ohta; Meenakshi Subramanian; Manasa Madasu; Michail Sitkovsky
Journal:  Front Immunol       Date:  2012-07-05       Impact factor: 7.561

Review 6.  Regulating the adaptive immune response to respiratory virus infection.

Authors:  Thomas J Braciale; Jie Sun; Taeg S Kim
Journal:  Nat Rev Immunol       Date:  2012-03-09       Impact factor: 53.106

Review 7.  Molecular signatures of T-cell inhibition in HIV-1 infection.

Authors:  Marie Larsson; Esaki M Shankar; Karlhans F Che; Alireza Saeidi; Rada Ellegård; Muttiah Barathan; Vijayakumar Velu; Adeeba Kamarulzaman
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

Review 8.  Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.

Authors:  Milan Buc
Journal:  Mediators Inflamm       Date:  2013-05-12       Impact factor: 4.711

9.  Anti-CD25 treatment depletes Treg cells and decreases disease severity in susceptible and resistant mice infected with Paracoccidioides brasiliensis.

Authors:  Maíra Felonato; Adriana Pina; Eliseu Frank de Araujo; Flávio V Loures; Silvia B Bazan; Cláudia Feriotti; Vera L G Calich
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Inducing and Administering Tregs to Treat Human Disease.

Authors:  Ana Luisa Perdigoto; Lucienne Chatenoud; Jeffrey A Bluestone; Kevan C Herold
Journal:  Front Immunol       Date:  2016-01-22       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.